The nurse is caring for a patient who has a diagnosis of AIDS. Inspection of the patient's mouth reveals the new presence of white lesions on the patient's oral mucosa. What is the nurse's most appropriate response?
A) Encourage the patient to gargle with salt water twice daily.
B) Attempt to remove the lesions with a tongue depressor.
C) Make a referral to the unit's dietitian.
D) Inform the primary care provider of this finding.
Ans: D
Feedback:
The nurse should inform the primary care provider of this abnormal finding in the patient's oral cavity, since it necessitates medical treatment. It would be inappropriate to try to remove skin lesions from a patient's mouth and salt water will not resolve this problem, which is likely due to candidiasis. A dietitian referral is unnecessary.
You might also like to view...
Nursing codes of ethics have several purposes, including Standard Text: Select all that apply
1. Informing the public about minimum standards that acceptable for nursing conduct 2. Outlines the major ethical considerations of the profession 3. General guidelines for nurses to follow regarding professional behavior 4. Mandates regulation 5. Provides a sign of the profession's commitment to itself
When assessing a group of individuals for factors related to an increased risk for alcohol use disorders, which of the following would the nurse expect to find?
A) Social anxiety difficulties B) Low level of antisocial behavior C) Decreased impulsivity D) Focused attention
A client weighing 132 lb is brought to the emergency department in status epilepticus. The physician asks the nurse to prepare diazepam (Valium) 0.25 mg/kg. How many milligrams will be given to this client? _______________________________ mg
Fill in the blank(s) with correct word
A client with chronic renal failure has begun treatment with a colony-stimulating factor. What medication does the nurse anticipate administering to the client that will promote the production of blood cells?
A) Etanercept (Enbrel) B) infliximab (Remicade) C) Epoetin alfa (Epogen) D) Adalimumab (Humira)